N-(5-chloro-2,3-dihydroinden-1-ylidene)hydroxylamine结构式
|
常用名 | N-(5-chloro-2,3-dihydroinden-1-ylidene)hydroxylamine | 英文名 | N-(5-chloro-2,3-dihydroinden-1-ylidene)hydroxylamine |
|---|---|---|---|---|
| CAS号 | 90537-19-2 | 分子量 | 181.61900 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C9H8ClNO | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-(5-chloro-2,3-dihydroinden-1-ylidene)hydroxylamine |
|---|---|
| 英文别名 | 更多 |
| 分子式 | C9H8ClNO |
|---|---|
| 分子量 | 181.61900 |
| 精确质量 | 181.02900 |
| PSA | 32.59000 |
| LogP | 2.46450 |
|
~76%
N-(5-chloro-2,3... 90537-19-2 |
| 文献：PATHWAY THERAPEUTICS INC.; BROWN, David, S.; MATTHEWS, David, J. Patent: WO2012/135166 A1, 2012 ; Location in patent: Page/Page column 77-78 ; WO 2012/135166 A1 |
| 5-Chlor-indan-1-on-oxim |
| 5-chloro-indan-1-one oxime |
| HMS2154M05 |
| 5-Chlor-1-indanon-oxim |
| 5-Chlor-indan-1-on-oim |
| 5-CHLORO-1-INDANONE OXIME |
| 5-Chlor-indanon-(1)-oxim |
